Brain Tumor Treatment Satisfaction Survey

Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00557375

Enrollment

105

Registered

2007-11-14

Start date

2007-06-01

Completion date

2009-03-01

Last updated

2022-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumors

Keywords

Brain Tumors, Survey

Brief summary

Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.

Detailed description

Patients with a recent diagnosis and treatment of a brain tumor (primary or metastatic; N=105, 61% female, 39% male) were identified in the clinics of Semmes-Murphey Neurologic and Spine Institute or the Methodist University Hospital in Memphis, TN. Caregivers were recruited from among relatives and friends who provide the most day-to-day care to the patient. All participants were between 3 months and 1 year from their most recent brain tumor treatment. Participants were given a simple, 5-point based survey to asses treatment-specific satisfaction, patient education, posttreatment quality of life, and pre- and post-treatment emotional impact. Therapeutic modalities surveyed include: surgery, external beam radiotherapy, whole-brain radiotherapy, stereotactic radiosurgery, and chemotherapy.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients who are between 3 months and one year out from treatment for their brain tumor * Karnofsky Performance Status (KPS) \>= 60 * Age 18 years or over, any gender, any race * patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients

Exclusion criteria

* No exclusions

Design outcomes

Primary

Measure	Time frame
Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors.	(greater than or equal to 3 months) from first treatment for brain tumor

Secondary

Measure	Time frame
Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver.	(Greater than or equal to 3 months) from first treatment for brain tumor

Countries

United States

Outcome results